Upstream Bio (UPB) Current Assets (2023 - 2025)
Historic Current Assets for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $389.0 million.
- Upstream Bio's Current Assets rose 7116.73% to $389.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $389.0 million, marking a year-over-year increase of 7116.73%. This contributed to the annual value of $479.2 million for FY2024, which is 30955.25% up from last year.
- Per Upstream Bio's latest filing, its Current Assets stood at $389.0 million for Q3 2025, which was up 7116.73% from $418.3 million recorded in Q2 2025.
- Upstream Bio's Current Assets' 5-year high stood at $479.2 million during Q4 2024, with a 5-year trough of $117.0 million in Q4 2023.
- For the 3-year period, Upstream Bio's Current Assets averaged around $347.4 million, with its median value being $403.6 million (2025).
- Per our database at Business Quant, Upstream Bio's Current Assets skyrocketed by 30955.25% in 2024 and then skyrocketed by 7116.73% in 2025.
- Over the past 3 years, Upstream Bio's Current Assets (Quarter) stood at $117.0 million in 2023, then soared by 309.55% to $479.2 million in 2024, then dropped by 18.81% to $389.0 million in 2025.
- Its Current Assets was $389.0 million in Q3 2025, compared to $418.3 million in Q2 2025 and $453.8 million in Q1 2025.